Effect of hyperbaric oxygenation on mitochondrial function of neuronal cells in the cortex of neonatal rats after hypoxic-ischemic brain damage

Abstract

The timing and mechanisms of protection by hyperbaric oxygenation (HBO) in hypoxic-ischemic brain damage (HIBD) have only been partially elucidated. We monitored the effect of HBO on the mitochondrial function of neuronal cells in the cerebral cortex of neonatal rats after HIBD. Neonatal Sprague-Dawley rats (total of 360 of both genders) were randomly divided into normal control, HIBD, and HIBD+HBO groups. The HBO treatment began immediately after hypoxia-ischemia (HI) and continued once a day for 7 consecutive days. Animals were euthanized 0, 2, 4, 6, and 12 h post-HI to monitor the changes in mitochondrial membrane potential (ΔΨm) occurring soon after a single dose of HBO treatment, as well as 2, 3, 4, 5, 6, and 7 days post-HI to study ΔΨm changes after a series of HBO treatments. Fluctuations in ΔΨm were observed in the ipsilateral cortex in both HIBD and HIBD+HBO groups. Within 2 to 12 h after HI insult, the ΔΨm of the HIBD and HIBD+HBO groups recovered to some extent. A secondary drop in ΔΨm was observed in both groups during the 1-4 days post-HI period, but was more severe in the HIBD+HBO group. There was a secondary recovery of ΔΨm observed in the HIBD+HBO group, but not in the HIBD group, during the 5-7 days period after HI insult. HBO therapy may not lead to improvement of neural cell mitochondrial function in the cerebral cortex in the early stage post-HI, but may improve it in the sub-acute stage post-HI.

Miro1 Enhances Mitochondria Transfer from Multipotent Mesenchymal Stem Cells (MMSC) to Neural Cells and Improves the Efficacy of Cell Recovery

“…It is well known that ischemic stroke is associated with oxidative stress and severe impairments of mitochondrial functioning in the damaged brain region [ 35 ]. Numerous studies have demonstrated that the protection of the mitochondria of neural cells from damage can be an effective therapeutic approach for the treatment of acute neurological disorders [ 36 , 37 , 38 , 39 ]. Most of these strategies consisted in either antioxidant usage to decrease excessive levels of ROS or in the induction of signaling cascades associated with preconditioning that ultimately prevented the increase of mitochondrial permeability.…”

Prophylactic treatment of hyperbaric oxygen treatment mitigates inflammatory response via mitochondria transfer

“…Mitochondrial dysfunction stands as a therapeutic target in stroke and TBI due to its role in the secondary injury mechanism. 41,42 However, HBOT as a treatment for cerebrovascular diseases has yielded mixed results. 14 The initiation of HBOT may dictate the therapeutic, or detrimental, outcomes.…”

Notoginsenoside R1 Alleviates Oxygen–Glucose Deprivation/Reoxygenation Injury by Suppressing Endoplasmic Reticulum Calcium Release via PLC

“…Hypoxic–ischemic encephalopathy (HIE) is a severe brain disease with high morbidity and mortality worldwide 1 . Typically, HIE causes irreversible necrosis, cell apoptosis, and neuron death, which can lead to permanent neurological morbidity 2 . Our previous study revealed that notoginsenoside R1 (NGR1) protects the brain from hypoxic–ischemic injury through the inhibition of endoplasmic reticulum (ER) stress pathways 3 .…”